KAS
DGX icon

Kemnay Advisory Services’s Quest Diagnostics DGX Stock Holding History

Kemnay Advisory Services’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-44
Closed -$8.62K – 1227
2026
Q1 		$8.62K Buy
+44
New +$8.55K ﹤0.01% 1038
2017
Q4 		– Sell
-8,747
Closed -$819K – 119
2017
Q3 		$819K Buy
8,747
+1,465
+20% +$156K 0.35% 48
2017
Q2 		$809K Buy
+7,282
New +$770K 0.47% 43

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Kemnay Advisory Services's DGX Position: Q2 2026 in Review

Kemnay Advisory Services sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 44 shares — an estimated $8.62K sold.

Kemnay Advisory Services first reported a position in DGX in Q2 2017 and held it in 3 quarters. The position peaked at $819K in Q3 2017. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Kemnay Advisory Services reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
  • Kemnay Advisory Services sold 44 Quest Diagnostics shares in Q2 2026, an estimated $8.62K.
  • Kemnay Advisory Services first reported a position in Quest Diagnostics in Q2 2017 and held it in 3 quarters.
  • Kemnay Advisory Services's Quest Diagnostics position peaked at $819K in Q3 2017.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.